Download Citation
Article Source:
Concordance of real-world versus conventional progression-free survival from a phase 3 trial of endocrine therapy as first-line treatment for metastatic breast cancer
Huang Bartlett C,
Mardekian J,
Cotter MJ,
Huang X,
Zhang Z,
et al.
(2020)
Concordance of real-world versus conventional progression-free survival from a phase 3 trial of endocrine therapy as first-line treatment for metastatic breast cancer.
PLOS ONE 15(4): e0227256.
https://doi.org/10.1371/journal.pone.0227256